Intensity-modulated radiation therapy for head and neck cancer

Expert Review of Anticancer Therapy

Volumn 4, Issue 3, 2004, Pages 425-434

  De Neve, Wilfried ^a   Duthoy, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Head and neck cancer; IMRT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AUDITORY SYSTEM; CANCER CONTROL; CANCER RECURRENCE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ELECTRON BEAM; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX TUMOR; INTENSITY MODULATED RADIATION THERAPY; LACRIMAL GLAND; LARYNX TUMOR; MEDICAL RESEARCH; MOUTH TUMOR; NASOPHARYNX TUMOR; NOSE CAVITY CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX TUMOR; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; REVIEW; SALIVARY GLAND; TOXICITY; TREATMENT FAILURE; TUMOR VOLUME; VISUAL SYSTEM;

EID: 2942544488     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.3.425     Document Type: Review

References (45)

1. Brahme A, Roos JE, Lax I. Solution of an integral equation encountered in rotation therapy. Phys. Med Biol. 27, 1221-1229 (1982).
2. Lax I, Brahme A. Rotation therapy using a novel high-gradient filter. Radiology 145, 473-478 (1982).
3. Eklof A, Ahnesjo A, Brahme A. Photon beam energy deposition kernels for inverse radiotherapy planning. Acta Oncol. 29, 447-454 (1990).
4. Carol M, Grant WH III, Pavord D et al. Initial clinical experience with the Peacock intensity modulation of a 3D conformal radiation therapy system. Stereotact. Funct. Neurosurg. 66,30-34 (1996).
5. Eisbruch A, Ship JA, Martel MK et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int. J. Radiat. Oncol. Biol. Phys. 36, 469-480 (1996).
6. Eisbruch A, Marsh LH, Marto MK et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int. J. Radiat. Oncol. Biol. Phys. 41, 559-568 (1998).
7. Teh BS, Mai WY, Grant WH III et al. Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest. 20, 437-451 (2002).
8. Chao KS, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int. J. Cancer 90, 92-103 (2000).
9. Claus F, Boterberg T, Ost P, De Neve W. Short-term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother. Oncol. 64, 205-208 (2002).
10. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head and neck cancer: the UCSF experience focusing on target volume delineation. Int. J. Radiat. Oncol. Biol. Phys. 57, 49-60 (2003).
11. Verellen D, Linthout N, Storme G. Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. The AZ-VUB experience. Strahlenther. Onkol. 174(Suppl. 2), 19-27 (1998).
12. Cozzi L, Fogliata A. IMRT in the treatment of head and neck cancer: is the present already the future? Expert Rev. Anticancer Ther. 2, 297-308 (2002).
13. De Neve W, Claus F, Van Houtte P, Derycke S, De Wagter C. Intensity modulated radiotherapy with dynamic multileaf collimator. Technique and clinical experience. Cancer Radiother. 3, 378-392 (1999).
14. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 46, 619-630 (2000).
15. De Neve W, De Gersem W, Derycke S et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother. Oncol. 50, 301-314 (1999).
16. Claus F, Duthoy W, Boterberg T et al. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol. 38, 597-604 (2002).
17. Claus F, De Gersem W, De Wagter C et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int. J. Radiat. Oncol. Biol. Phys. 51, 318-331 (2001).
18. Tsien C, Eisbruch A, McShan D, Kessler M, Marsh R, Fraass B. Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process. Int. J. Radiat. Oncol. Biol. Phys. 55, 776-784 (2003).
19. Penagaricano JA, Papanikolaou N. Intensity-modulated radiotherapy for carcinoma of the head and neck. Curr. Oncol. Rep. 5, 131-139 (2003).
20. Teh BS, Woo SY, Butler EB. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist 4, 433-442 (1999).
21. Dogan N, Leybovich LB, King S, Sethi A, Emami B. Improvement of treatment plans developed with intensity-modulated radiation therapy for concave-shaped head and neck tumors. Radiology 223, 57-64 (2002).
22. Hunt MA, Zelefsky MJ, Wolden S et al. Treatment platming and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int. J. Radiat. Oncol. Biol. Phys. 49, 623-632 (2001).
23. Cozzi L, Fogliata A, Bolsi A, Nicolini G, Bernier J. Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int. J. Radiat. Oncol. Biol. Phys. 58, 617-624 (2004).
24. Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 58, 147-154 (2004).
25. Eisbruch A, Dawson LA, Kim HM et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function and quality of life. Acta Otorhinolaryngol. Belg. 53, 271-275 (1999).
26. Dawson LA, Anzai Y, Marsh L et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int. J. Radiat. Oncol Biol. Phys. 46, 1117-1126 (2000).
27. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int. J. Radiat. Oncol. Biol. Phys. 53, 12-22 (2002).
28. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 55, 312-321 (2003).
29. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 45, 577-587 (1999).
30. Amosson CM, Teh BS, Van TJ et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int. J. Radiat. Oncol. Biol. Phys. 56, 136-144 (2003).
31. Butler EB, Teh BS, Grant WH III et al. Snurt (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 45, 21-32 (1999).
32. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int. J. Radiat. Oncol. Biol. Phys. 56, 573-585 (2003).
33. Tate DJ, Adler JR Jr, Chang SD et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int. J. Radiat. 0ncol. Biol. Phys. 45, 915-921 (1999).
34. DeNittis AS, Liu L, Rosenthal DI, Machtay M. Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy and concurrent/adjuvant chemotherapy. Am. J. Clin. Oncol. 25, 93-95 (2002).
35. Rudoltz MS, Perkins RS, Luthmann RW et al. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. Laryngoscope 109, 1967-1973 (1999).
36. Gregoire V. Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU. Cancer Radiother. 6(Suppl. 1), 29S-31S (2002).
37. Ling CC, Humm J, Larson S et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int. J. Radiat. Oncol. Biol. Phys. 47, 551-560 (2000).
38. Van de Wiele C, Lahorte C, Oyen W et al. Nuclear medicine imaging to predict response to radiotherapy: a review. Int. J. Radiat. Oncol. Biol. Phys. 55, 5-15 (2003).
39. Chao KS, Bosch WR, Mutic S et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 49, 1171-1182 (2001).
40. Daisne JF, Sibomana M, Bol A et al. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. Radiother. Oncol. 69, 237-245 (2003).
41. DeNeve W, Duthoy W, Claus F et al. Dose conformation in IMRT for head and neck tumors: which solution to apply? Cancer Radiother. 6(Suppl. 1), 32S-36S (2002).
42. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys. 30(4), 775-780 (1994).
43. Bessell EM, Henk JM, Whitelocke RA, Wright JE. Ocular morbidity after radiotherapy of orbital and conjunctival lymphoma. Eye 1(Pt 1), 90-96 (1987).
44. Letschert JG, Gonzalez Gonzalez D, Oskam J et al. Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma. Radiother Oncol. 22(1), 36-44 (1991).
45. Morita K Kawabe Y. Late effeccs on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity. Radiology 130(1), 227-232 (1979).